Scientific Digital Imaging’s Synoptics Health Division, a manufacturer of digital imaging systems for healthcare applications, has upgraded the ProReveal Protein Detection Test with advanced process validation analytics software for detecting and analysing the amount of residual protein on surgical instruments post-decontamination. The new ProReveal also determines the effectiveness of the decontamination process, which will help hospitals to improve the cleanliness of their surgical instruments.
The ProReveal Test combines a touch screen ProReveal Viewer with a new analytics software module and ProReveal fluorescence-based Protein Test Kit.
The software analyses images and quantitative data generated by the ProReveal Viewer to determine where and how much protein remains on surgical instruments. Process criteria such as washing machine, tray number and position, detergent, operator and programme details can all be monitored to provide an overview of how effectively the decontamination processes are performing over time.
The addition of the analytics software means the ProReveal is now capable of being a precise diagnostic tool, allowing AEDs (Authorising Engineers Decontamination) in hospitals to validate and standardise every stage of their disinfection processes or manufacturers of decontamination equipment and detergents to optimise their products for maximum protein removal.
Paul Ellwood, CEO of Synoptics Health, said: 'Our new ProReveal Test uses very sensitive fluorescence technology and unlike existing tests used in hospitals will tell you exactly how much protein is on your surgical instrument and where it is, and now how successful all aspects of your decontamination process are.'
He added: 'This is a totally different approach from current testing and is a significant breakthrough because for the first time hospitals can accurately standardise and validate the decontamination process.'
